A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
There is no single approach to treating prostate cancer. Treatment options depend upon the risk group and patient factors and preferences. A patient who receives a diagnosis of localized or locally ...
Addition of 6 months of androgen deprivation therapy to stereotactic body radiotherapy more than doubled PFS in hormone-sensitive oligorecurrent prostate cancer. Nearly all patients treated with the ...
A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.
Please provide your email address to receive an email when new articles are posted on . Treatment intensification for prostate cancer is underutilized due to numerous barriers, including knowledge ...
The procedure marks a significant advancement in urological surgery and men’s health American Hospital Dubai has achieved a groundbreaking medical milestone with the successful completion of the ...
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
The long-term outlook for men diagnosed with prostate cancer continues to improve. About 98% are living for 10 years or more after diagnosis, and the survival rate at 15 years now exceeds 95%. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback